Learn More
Knowledge of hepatitis B and C prevalence, and numbers infected, are important for planning responses. Published HBsAg and anti-HCV prevalences for the 20 WHO European Region countries outside the EU/EFTA were extracted, to complement published data for the EU/EFTA. The general population prevalence of HBsAg (median 3·8%, mean 5·0%, seven countries) ranged(More)
Every reasonable effort has been made to verify the accuracy of data and of all the information presented in this report. The opinions expressed in this publication are those of the contributing authors and do not necessarily reflect the policies or the views of UNICEF and WHO. 3 Towards the elimination of mother-to-child transmission of HIV in(More)
BACKGROUND Unsafe injections, through infectious bodily fluids, are a major route of transmission for hepatitis B and C. Viral hepatitis burden among people who inject drugs is particularly high in many Member States of central and Eastern Europe while national capacity and willingness to address it varies greatly. METHODS The initial survey included 43(More)
  • 1